title: Second-line chemotherapy in head and neck cancer: what should we expect?
authors.forename: Jens
authors.initials: J
authors.lastname: Büntzel
authors.forename: Oliver
authors.initials: O
authors.lastname: Micke
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D004305:Dose-Response Relationship, Drug; D006258:Head and Neck Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D006801:Humans
chemical_list: D000970:Antineoplastic Agents